Saliva, breast milk, and serum antibody responses as indirect measures of intestinal immunity after oral cholera vaccination or natural disease
- PMID: 3528211
- PMCID: PMC268875
- DOI: 10.1128/jcm.24.2.203-209.1986
Saliva, breast milk, and serum antibody responses as indirect measures of intestinal immunity after oral cholera vaccination or natural disease
Abstract
The possibility that antibody responses in serum, saliva, or breast milk samples to oral vaccines or enteric infections may reflect the intestinal immune response was evaluated in Bangladeshi volunteers orally immunized with a cholera B subunit-whole-cell vaccine (B + WCV) and in patients convalescing from enterotoxin-induced diarrheal disease. Two peroral doses of B + WCV induced antitoxin and antibacterial antibody responses in the intestinal fluids of 76 and 92%, respectively, of the volunteers and in serum samples in 90 and 69% of those tested. These responses were comparable to those obtained after cholera or enterotoxigenic Escherichia coli disease. Whereas immunoglobulin A (IgA) antitoxin titer increases in saliva (44%) and breast milk (29%) specimens after vaccination were less frequent than in intestinal fluid (76%), antitoxin responses in saliva and breast milk occurred in 80 to 90% of the patients after disease. Also, antilipopolysaccharide (anti-LPS) titer increases in extraintestinal body fluids were found more frequently after disease than after vaccination. A comparison of the frequency and magnitude of antibody response in different body fluids with those in intestinal lavage fluid revealed no extraintestinal antibody that directly reflected the intestinal immunity. However, comparison of vibriocidal and IgG antitoxin antibodies in serum specimens with antitoxin and anti-LPS IgA responses in intestinal fluids after the vaccination of volunteers showed a sensitivity of 70 to 90% and a predictive accuracy of about 80% for the serum analyses reflecting the intestinal immune responses. Furthermore, antitoxin and anti-LPS antibody responses in saliva and breast milk samples seemed to be useful proxy indicators of a gut mucosal response of these antibodies after enterotoxin-induced diarrheal disease showing sensitivity vales of 70 to 90% and predictive accuracy vales of 70 to 100%.
Similar articles
-
Mucosal antitoxic and antibacterial immunity after cholera disease and after immunization with a combined B subunit-whole cell vaccine.J Infect Dis. 1984 Jun;149(6):884-93. doi: 10.1093/infdis/149.6.884. J Infect Dis. 1984. PMID: 6736680
-
Safety and immunogenicity of oral killed whole cell recombinant B subunit cholera vaccine in Barranquilla, Colombia.Bull Pan Am Health Organ. 1995 Dec;29(4):312-21. Bull Pan Am Health Organ. 1995. PMID: 8605522 Clinical Trial.
-
Field trial of oral cholera vaccines in Bangladesh: evaluation of anti-bacterial and anti-toxic breast-milk immunity in response to ingestion of the vaccines.Vaccine. 1990 Oct;8(5):469-72. doi: 10.1016/0264-410x(90)90248-k. Vaccine. 1990. PMID: 2251873 Clinical Trial.
-
Cholera as a model for research on mucosal immunity and development of oral vaccines.Curr Opin Immunol. 1992 Aug;4(4):387-91. doi: 10.1016/s0952-7915(06)80027-0. Curr Opin Immunol. 1992. PMID: 1388838 Review.
-
Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier, and adjuvant.Am J Trop Med Hyg. 1994;50(5 Suppl):42-54. Am J Trop Med Hyg. 1994. PMID: 8203723 Review.
Cited by
-
Enterotoxin-specific immunoglobulin E responses in humans after infection or vaccination with diarrhea-causing enteropathogens.Infect Immun. 2000 Oct;68(10):6077-81. doi: 10.1128/IAI.68.10.6077-6081.2000. Infect Immun. 2000. PMID: 10992527 Free PMC article.
-
Dose-dependent circulating immunoglobulin A antibody-secreting cell and serum antibody responses in Swedish volunteers to an oral inactivated enterotoxigenic Escherichia coli vaccine.Clin Diagn Lab Immunol. 2001 Mar;8(2):424-8. doi: 10.1128/CDLI.8.2.424-428.2001. Clin Diagn Lab Immunol. 2001. PMID: 11238232 Free PMC article. Clinical Trial.
-
Small intestinal mucosal protection mechanisms and their importance in rheumatology.Ann Rheum Dis. 1991 May;50(5):331-6. doi: 10.1136/ard.50.5.331. Ann Rheum Dis. 1991. PMID: 2042991 Free PMC article. Review. No abstract available.
-
Immunoglobulin A response to SARS-CoV-2 infection and immunity.Heliyon. 2024 Jan 3;10(1):e24031. doi: 10.1016/j.heliyon.2024.e24031. eCollection 2024 Jan 15. Heliyon. 2024. PMID: 38230244 Free PMC article. Review.
-
Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina.Infect Immun. 1997 Jul;65(7):2676-84. doi: 10.1128/iai.65.7.2676-2684.1997. Infect Immun. 1997. PMID: 9199436 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous